Daily analysis of Indian market events grounded in real corporate filings. Every claim is backed by what companies actually said in their annual reports and quarterly results.
Delhi proposes phasing out petrol two-wheelers and offering Rs 1 lakh scrappage incentives. We dig into company filings to find which EV makers stand to gain and which ICE-dependent firms face risk.
The India-UK FTA takes effect in May 2026 with tariff cuts across sectors. We dug into filings to find which Indian exporters have the most UK revenue at stake.
The Israel-Iran conflict is disrupting key solvent and feedstock supplies for Indian pharma companies. We dig into filings to find which companies face margin pressure and which are better positioned.
AERA ordered Indian airports to cut some charges 25%. GMR Airports and Adani Enterprises take the hit, but IndiGo's ₹5,753 crore airport fees line means airlines are the hidden winner.
India moved gold and silver jewellery imports into the restricted category. Filing evidence shows Titan, MVGJL, Motisons and Sky Gold as structural beneficiaries of the policy tilt toward domestic, branded supply.
The US 100% tariff on patented drug imports targets Big Pharma, not Indian generics. Here are 5 NSE-listed companies whose filings show they are positioned to benefit as American buyers accelerate the switch to off-patent alternatives.
The government has exempted customs duty on critical petrochemical products till June 30 amid the West Asia crisis. Here are five NSE-listed companies whose margins could improve.
While West Asia dominates headlines, China is quietly pulling ahead in biologics manufacturing. We dig into filings to see which Indian pharma companies are best prepared and which are falling behind.
US tariffs squeeze Indian garment exporters, but new trade deals with EU and UK are opening doors for electronics manufacturers and medical device makers. We dig into the filings.
As crude oil surges on Iran-Hormuz tensions and the Sensex crashes 1,700 points, renewable energy and solar stocks with strong order books stand to gain from accelerated energy transition.
The government is considering invoking the Essential Commodities Act to regulate bulk drug prices. We dig into filings to find which API makers face margin pressure and which formulation companies could benefit from cheaper inputs.
The West Asia conflict is pushing crude oil higher. We dug into quarterly filings of IndiGo, HINDPETRO, BPCL, Asian Paints, and Oil India to see who gets hurt — and who quietly benefits.
A US Supreme Court ruling rolled back Trump's 50% tariffs on India to 15%. We dug into corporate filings to find which NSE-listed exporters have the most US revenue exposure — and the most to gain.
The India-US tariff reset has cut duties on Indian textiles to 18%. We dug into filings of Welspun Living, Trident, Indo Count and others to find who benefits most.
DCGI intensifies enforcement against unauthorized GLP-1 weight-loss drugs. Filing evidence shows these five companies are building legitimate semaglutide pipelines and delivery devices.